"
Team:HokkaidoU Japan/Safety
From 2011.igem.org
| Line 3: | Line 3: | ||
{| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center" | {| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center" | ||
!align="center"|[[Team:HokkaidoU_Japan|Home]] | !align="center"|[[Team:HokkaidoU_Japan|Home]] | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
!align="center"|[[Team:HokkaidoU_Japan/Safety|Safety]] | !align="center"|[[Team:HokkaidoU_Japan/Safety|Safety]] | ||
| - | |||
|} | |} | ||
Revision as of 01:36, 3 September 2011
| Home | Safety |
|---|
Safety
1. Would any of your project ideas raise safety issues in terms of:
- researcher safety,
- public safety, or
- environmental safety?
_Our study will not contain any manipulation associated with pathogenic bacteria, live salmonella bacteria. Although we are planning to use a part of Salmonella's genome which was obtained from Salmonella Genetic Stock Centre (SGSC), our instructor obtained appropriate permission from the safety officer of genetic recombination in our universities. These E. coli were acknowledged as non-pathogenic and permitted to be used under P1 safety level.
Our lab is equipped appropriately for the manipulation of genetic recombination. Team members are instructed according to the safety training manual.
2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,
- did you document these issues in the Registry?
- how did you manage to handle the safety issue?
- How could other teams learn from your experience?
Currently there are no BioBricks which raise any safety issues.
3. Is there a local biosafety group, committee, or review board at your institution?
- If yes, what does your local biosafety group think about your project?
- If no, which specific biosafety rules or guidelines do you have to consider in your country?
We have “the safety office of genetic recombination in Hokkaido University”.
4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?
Currently we don`t have any suggestions.
